Patent details

Basic Information

Publication number:

EP1140835

PCT Application Number:

PCT/IB/1999/001914

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP999562689

PCT Publication Number:

WO/2000/039091

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

3,3-BIARYLPIPERIDINE AND 2,2-BIARYLMORPHOLINE DERIVATIVES

French Title of Invention:

DERIVES 3,3-BIARYLPIPERIDINE AND 2,2-BIARYLMORPHOLINE

German Title of Invention:

3,3-BIARYLPIPERIDIN- UND 3,3-BIARYLMORPHOLINDERIVATE

SPC Number:

Dates

Filing date:

01/12/1999

Grant date:

12/05/2004

EP Publication Date:

12/05/2004

PCT Publication Date:

06/07/2000

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

10/10/2001

EP B1 Publication Date:

12/05/2004

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

01/12/2005

Expiration date:

01/12/2019

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

01/12/1999

 

 

Name:

Pfizer Products Inc.

Address:

Eastern Point Road, Groton, Connecticut 06340, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

12/05/2004

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

LIRAS Spiros

Address:

United States (US)

2

Name:

SEGELSTEIN Barbara, Eileen

Address:

United States (US)

3

Name:

ALLEN Martin, Patrick

Address:

United States (US)

Priority

Priority Number:

114091 P

Priority Date:

29/12/1998

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 211/34;

Filing date	Document type	Number of pages